ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2552

Changes in Social Determinants of Health Needs Uncovered by a Rheumatology-Based Screening and Assistance Program

Haelynn Gim1, Rebecca Summit2, Karli Retzel2, Leah Santacroce2, Virginia Bills3, Nancy Shadick2, Sara Schoenfeld4 and Candace Feldman2, 1Harvard Medical School, Brookline, MA, 2Brigham and Women's Hospital, Boston, MA, 3Mass General Brigham, Boston, MA, 4Massachusetts General Hospital, Boston, MA

Meeting: ACR Convergence 2024

Keywords: Disparities, socioeconomic factors, Surveys

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 18, 2024

Title: Abstracts: Healthcare Disparities in Rheumatology

Session Type: Abstract Session

Session Time: 1:00PM-2:30PM

Background/Purpose: Social determinants of health (SDoH), including non-medical social needs and adverse environmental exposures, contribute to inequities in rheumatic disease care and outcomes. Patients with rheumatic conditions receive extensive care in the subspecialty setting, where SDoH are infrequently documented and infrastructure to address needs is lacking. We implemented SDoH screening in a multihospital system, offered assistance to help address needs, and examined changes in SDoH needs on a subsequent screen.

Methods: We implemented an electronic health record-based SDoH screening survey for patients with upcoming appointments at 9 rheumatology clinics across 2 hospitals. Patients who indicated SDoH needs received need-specific lists of community resources, and those requesting further information received telephone outreach by a rheumatology-based Community Resource Specialist (CRS) with individually tailored guidance to facilitate access to resources. Patients who indicated “no information needed” received neither. Patients who missed the visit associated with a completed screen, or with a visit following minor modifications in screening procedures by the hospital system, were rescreened. We examined the prevalence of needs between the baseline (“Screen 1”) and subsequent (“Screen 2”) screen, completed ≥30 days apart, and used a Pearson’s chi-squared test to assess for a difference in persistence of ≥1 overall need between assistance groups. A need was considered persistent if it was present in both screens.

Results: Between 6/23/22-12/23/23, 10,521 adults (≥18 years) completed the rheumatology-based SDoH screening. Of these, 4,883 (46.4%) were rescreened (mean (SD) 196 (94) days between screens) (Table 1). Among those who completed both screens, 667 (14%) had ≥1 need in Screen 1 (mean (SD) 1.7 (1.3) needs). Individuals with (vs. without) needs were younger and a higher percentage were female, identified as Black or Hispanic, and were Spanish-speaking. In Screen 2, 363 (54%) of the 667 patients with ≥1 need on Screen 1 again had ≥1 need (mean (SD) 1.0 (1.3) needs). The most frequent needs in Screen 1 were food insecurity (34%), difficulty paying for utilities (30%), and medication access issues (27%); these needs also persisted across screens, with >50% with remaining needs. Patients requesting no information had the lowest percentages of need persistence. For all needs except medication access, patients who received CRS engagement were more likely to have persistent needs (Table 2).

Conclusion: This program revealed a significant burden of persistent and dynamic SDoH needs, demonstrating the importance of repeated rheumatology-based screening. Patients who received CRS assistance often had persistent needs on rescreen. Possible explanations include the presence of more complex needs, needs rooted in poverty requiring societal-level change and sustained support, and increased patient comfort disclosing their needs after initial CRS interaction. Further studies with random assignment to interventions and longer follow-up are needed to assess the impact of SDoH screening on rheumatic disease inequities.

Supporting image 1

Table 1. Characteristics of patients who completed Screens 1 and 2 between 6/23/22 – 1/23/24

Supporting image 2

Table 2. Social determinant of health need persistence across Screens 1 and 2 by need and assistance type


Disclosures: H. Gim: None; R. Summit: None; K. Retzel: None; L. Santacroce: None; V. Bills: None; N. Shadick: Abbbvie, 5, AQtual, 5, BMS, 5, Janssen, 5; S. Schoenfeld: None; C. Feldman: Bain Capital, LP, 2, BMS Foundation, 5, Curio Bioscience, 12, My husband is a founder and will (but has not to date) receive equity., Harvard Pilgrim, 2, OM1, Inc., 2.

To cite this abstract in AMA style:

Gim H, Summit R, Retzel K, Santacroce L, Bills V, Shadick N, Schoenfeld S, Feldman C. Changes in Social Determinants of Health Needs Uncovered by a Rheumatology-Based Screening and Assistance Program [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/changes-in-social-determinants-of-health-needs-uncovered-by-a-rheumatology-based-screening-and-assistance-program/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/changes-in-social-determinants-of-health-needs-uncovered-by-a-rheumatology-based-screening-and-assistance-program/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology